MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Bilateral Pallidal Deep Brain Stimulation in Secondary Dystonia in Louis-Bar-Syndrome Patients – A Report of Two Cases-

    N. Warneke, I. Claus, V. Zentsch, W. Stummer (Münster, Germany)

    Objective: Deep Brain Stimulation (DBS) is an established treatment for various movement disorders, including primary dystonia. The effect in secondary dystonia is less well studied.…
  • 2025 International Congress

    Diagnosis of GLUT1 Deficiency Syndrome in Adulthood

    A. Taneja, T. Thomas (Dallas, USA)

    Objective: To present a case of GLUT1 deficiency syndrome diagnosed in adulthood emphasizing the need to keep this diagnosis in differential for adult patients with…
  • 2025 International Congress

    Increased Health Care Utilization in Children/Adolescents With Tourette Syndrome Treated With Dopamine D2 Receptor Antagonists: An Electronic Medical Records Database Analysis

    D. Isaacs, J. Swindle, F. Dabbous, G. Karkanias, S. Atkinson, F. Munschauer, F. Mazhar, C. Pettersson, S. Wanaski, T. Cunniff, K. Tomczak (Nashville, USA)

    Objective: To compare health care resource utilization (HCRU) in dopamine D2 receptor antagonist (D2RA)-exposed versus D2RA non-exposed individuals with Tourette syndrome (TS). Background: TS is…
  • 2025 International Congress

    Design and Outcome Measures of BRAVE, a Phase 3 Study of Omaveloxolone in Pediatric Patients With Friedreich Ataxia

    D. Lynch, M. Delatycki, M. França, A. Durr, E. Bertini, S. Perlman, A. Arizpe, R. Domingo-Horne, S. Fradette, S. Sinks, M. Murai, N. Folschweiller (Philadelphia, USA)

    Objective: This phase 3 randomized controlled trial will assess the efficacy and safety of omaveloxolone in children aged 2 to <16 years. Background: Omaveloxolone is…
  • 2025 International Congress

    The Radiographic Overlap Between Normal Pressure Hydrocephalus (NPH) and Progressive Supranuclear Palsy (PSP): When Looks Can Be Deceiving

    R. Mani, C. Pol, M. Egnor, G. Schwartz (Stony Brook, USA)

    Objective: To demonstrate the overlap on radiographic metrics between NPH and PSP. Background: The neuroradiological hallmark of NPH is non-obstructive ventriculomegaly (Evans’ index (EI) >0.3).…
  • 2025 International Congress

    Analysis of the Association between SNCA Polymorphisms and the Risk of Multiple System Atrophy

    N. Abramycheva, M. Andreev, L. Karan, I. Minaev, A. Protopopova, A. Protsenko, E. Fedotova, S. Illaroshkin (Moscow, Russian Federation)

    Objective: To assess the impact of twenty-one single nucleotide polymorphisms (SNPs) located in different regulatory regions of the SNCA gene on the risk of developing…
  • 2025 International Congress

    Developing a novel Disease-Specific iPSC Model for Studying MSA Pathogenesis

    A. Perez-Soriano, M. Alemany-Ribes, B. Crespo, F. Kohler, B. Fuste, M. Perez-Soriano, D. Cohen, R. Fernandez-Santiago, M. Ezquerra, MJ. Martí, V. Baekelandt, W. Peelaerts, R. Melki, L. Batlle-Morera, . (Barcelona, Spain)

    Objective: This study aims to develop a human iPSC-derived oligodendrocyte (iPSC-OL) model to investigate cell-specific disease mechanisms in MSA. Specifically, we seek to:a)Generate MSA patient-derived…
  • 2025 International Congress

    Pathogenic TBK1 Mutation Associated with Multiple System Atrophy-Like Phenotype

    S. Barton, C. Siskind, H. Zahed (Palo Alto, USA)

    Objective: To report a novel case of an MSA-like phenotype in a patient with a pathogenic mutation in the TBK1 gene. Background: TANK-binding kinase 1…
  • 2025 International Congress

    Developing an Electronic Medical Record-Based Dystonia Tracking Tool for use in a Pediatric Hospital Setting

    L. Vogt, N. Al Azri, A. Leblanc-Millar, M. Eckstein, E. Patterson, S. Silver, C. Gorodetsky (Toronto, Canada)

    Objective: To develop an electronic medical record (EMR) tool for documenting and tracking dystonia severity in pediatric inpatients. Our goal was to enable easy input…
  • 2025 International Congress

    Identification of Cerebrotendinous Xanthomatosis in Patients with Neurodegenerative Disorders from the Cincinnati Cohort Biomarker Program

    L. Marsili, M. Kauffman, K. Duque, J. Abanto, R. Dutta, T. Pramparo, J. Terner-Rosenthal, A. Espay (Cincinnati, USA)

    Objective: To develop an algorithm for identifying patients with cerebrotendinous xanthomatosis (CTX) in a cohort of individuals with neurodegenerative disorders. Background: CTX is a rare…
  • « Previous Page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley